Who Paid My Doc
Acp-2566-004
ClinicalTrials.gov NCT04279314
Research payments
$2,717,988
Through program year 2024, $2,717,988 in research payments was reported against Acp-2566-004, across 302 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT04279314
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $5,931 | 2 |
| 2023 | Research | $213,460 | 25 |
| 2022 | Research | $1,035,575 | 136 |
| 2021 | Research | $1,154,477 | 102 |
| 2020 | Research | $308,545 | 37 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Constance Smith Hicks Baltimore, MD Named on 31 payments
- Robin Ryther Saint Louis, MO Named on 24 payments
- Elizabeth Berry-Kravis Chicago, IL Named on 22 payments
- Eric Marsh Philadelphia, PA Named on 15 payments
- Richard Haas San Diego, CA Named on 13 payments
- Randi Hagerman Davis, CA Named on 13 payments
- David Lieberman Boston, MA Named on 12 payments
- Shannon Standridge Cincinnati, OH Named on 12 payments
- Timothy Feyma Saint Paul, MN Named on 11 payments
- Yael Shiloh-Malawsky Chapel Hill, NC Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.